Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Liabilities ₹14,925 Cr₹13,309 Cr₹17,566 Cr₹15,397 Cr₹14,069 Cr

What is the latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹14,925 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹14,925 Cr
Mar2024₹13,309 Cr
Mar2023₹17,566 Cr
Mar2022₹15,397 Cr
Mar2021₹14,069 Cr

How is Total Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2025 ₹14,925 Cr
12.15
Mar2024 ₹13,309 Cr
-24.23
Mar2023 ₹17,566 Cr
14.08
Mar2022 ₹15,397 Cr
9.44
Mar2021 ₹14,069 Cr -

Compare Total Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,864.9 Cr 0.6% -7.2% 33.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,036.0 Cr 0.8% -4.2% 7% Stock Analytics
DIVIS LABORATORIES ₹178,218.0 Cr 1.1% -0.7% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,099.0 Cr 0% 1.3% 40.1% Stock Analytics
CIPLA ₹110,897.0 Cr -0.3% -4.1% -8.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,591.0 Cr 0.4% -4.5% -5.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.6%

-7.2%

33.4%

SENSEX

3.9%

1.9%

-6.8%


You may also like the below Video Courses